Home 2018-02-06T00:19:29+00:00

FIRST COMPANY DEDICATED TO SKELETAL AESTHETICS

Main visual image

OSTY MEDITECH is an innovation company that Develops, Manufactures, and Applies techniques that lead to new forms of beauty. We are the first to introduce the concept of “Skeletal Aesthetics.”

In the 1960s, breast augmentation became the first form of body aesthetic surgery, and body contouring fast became one of the most popular procedures for enhancing female attractiveness.
Pelvic plastic surgery, is designed to improve the aesthetic contour of the pelvic region, but until now, there was no genuine body skeletal aesthetics.

OSTY MEDITECH is changing that through the introduction of a new implant and surgical procedure that changes the body contour and gives women the “hourglass” shape they’ve always desired but didn’t know how to achieve.

OSTYMEDITECH

BOARD OF ADVISORS

line
DANIEL YOUGUN WON
DANIEL YOUGUN WONMD - FOUNDER & CEO
Dr Won is an Orthopedic Surgeon and an assistant Professor at Konyang University Hospital in South Korea. He is currently also serving as a research fellow at Harvard Medical School
MICHAEL WEAVER
MICHAEL WEAVERMD
Assistant Professor of Orthopedics, Harvard Medical School
ARA NAZARIAN
ARA NAZARIANPHD
Assistant Professor of Bio-Engineering, Harvard Medical School
TAEHYUNG KIM
TAEHYUNG KIMMD, CTO
Cosmetic Surgeon Former Research Fellow of Yonsei University
KWANG WON PAK
KWANG WON PAKMD
Orthopedic Surgeon Clinical Assistant Professor of Department of Orthopaedic Surgery Research Fellow of Boston Children’s Hospital

OSTYMEDITECH VIDEO

PELVIC PLASTY PROCEDURE

line
 Pelvic bone

PELVIC PLASTY PROCEDURE

Osty Meditech founder Yougun Won has pioneered the approach known as “Pelvic Plasty.” Under his skilful hand, this minimally invasive surgical procedure can change lives and give women the the look and apperance they’ve always dreamed about.

ILYAC Plate

SELLING ILYAC PLATE DEVICE

Osty Meditech is the producer of a minimally invasive plate device, which can inserted on the crest of the pelvic bone with an incision size less than 2cm size. The device will be sold directly to provider networks, but also wholesale distributors and agents. Following FDA clinical trials, the plate is expected to be available to orthopedic surgeons by late 2017